Direct medical costs of adverse events in Dutch hospitals
2009

Direct Medical Costs of Adverse Events in Dutch Hospitals

Sample size: 7889 publication Evidence: moderate

Author Information

Author(s): Hoonhout Lilian HF, de Bruijne Martine C, Wagner Cordula, Zegers Marieke, Waaijman Roelof, Spreeuwenberg Peter, Asscheman Henk, van der Wal Gerrit, van Tulder Maurits W

Primary Institution: VU University Medical Centre (VUmc)

Hypothesis

What are the total direct medical costs associated with adverse events and preventable adverse events in Dutch hospitals?

Conclusion

Preventable adverse events account for a significant portion of the national health care budget, primarily due to excess hospital stays.

Supporting Evidence

  • The annual direct medical costs for all adverse events were estimated at €355 million.
  • Preventable adverse events accounted for €161 million of the total costs.
  • 30,000 hospital admissions involved preventable adverse events, representing 2.3% of all admissions.

Takeaway

When patients have problems in the hospital that could have been avoided, it costs a lot of money because they have to stay longer.

Methodology

The study involved a retrospective review of patient records from 21 hospitals, assessing direct medical costs related to adverse events.

Potential Biases

Potential biases may arise from retrospective analysis and the subjective nature of determining adverse events.

Limitations

The study may underestimate costs due to incomplete data and underreporting of non-invasive procedures.

Participant Demographics

{"mean_age":57.5,"sex_distribution":{"male":49,"female":51}}

Statistical Information

Confidence Interval

95% CI: €316 million – €398 million for all AEs; €134 million – €195 million for preventable AEs

Digital Object Identifier (DOI)

10.1186/1472-6963-9-27

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication